Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Alkermes plc

ALKSNASDAQ
Healthcare
Biotechnology
$32.19
$0.28(0.88%)
U.S. Market opens in 14h 7m

Alkermes plc (ALKS) Stock Overview

Explore Alkermes plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.3B
P/E Ratio15.71
EPS (TTM)$2.01
ROE0.21%
Fundamental Analysis

AI Price Forecasts

1 Month$31.33
3 Months$29.60
1 Year Target$30.36

ALKS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Alkermes plc (ALKS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $30.36.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.71 and a market capitalization of 5.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.88%
5-Day Change
-2.07%
1-Month Change
-4.22%
3-Month Change
12.51%
6-Month Change
8.20%
Year-to-Date (YTD) Change
13.91%
1-Year Change
-9.38%
3-Year Change
17.65%
5-Year Change
63.82%
All-Time (Max) Change
485.27%

Contact Information

353 1 772 8000
Connaught House, Dublin, NaN, 4

Company Facts

18,000 Employees
IPO DateJul 16, 1991
CountryIE
Actively Trading

Frequently Asked Questions